Cargando…

Fecal Microbiome Data Distinguish Liver Recipients With Normal and Abnormal Liver Function From Healthy Controls

Emerging evidence suggests that altered intestinal microbiota plays an important role in the pathogenesis of many liver diseases, mainly by promoting inflammation via the “intestinal microbiota-immunity-liver” axis. We aimed to investigate the fecal microbiome of liver recipients with abnormal/norma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hai-Feng, Ren, Zhi-Gang, Li, Ang, Zhang, Hua, Xu, Shao-Yan, Jiang, Jian-Wen, Zhou, Lin, Ling, Qi, Wang, Bao-Hong, Cui, Guang-Ying, Chen, Xin-Hua, Zheng, Shu-Sen, Li, Lan-Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619441/ https://www.ncbi.nlm.nih.gov/pubmed/31333622 http://dx.doi.org/10.3389/fmicb.2019.01518

Ejemplares similares

Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
por: Lou, Jiamin, et al.
Publicado: (2020)

Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls
por: Lu, Haifeng, et al.
Publicado: (2019)

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis
por: Chen, Yanfei, et al.
Publicado: (2014)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Optimal immunosuppressor induces stable gut microbiota after liver transplantation
por: Jiang, Jian-Wen, et al.
Publicado: (2018)

Role of bile acids in liver diseases mediated by the gut microbiome
por: Shao, Jun-Wei, et al.
Publicado: (2021)

1212. Temporal Dynamics of the Plasma Microbiome in Recipients at Early Post-liver Transplantation
por: Okumura, Toshihiko, et al.
Publicado: (2020)

Fecal Microbiome Analysis Distinguishes Bacterial Taxa Biomarkers Associated with Red Fillet Color in Rainbow Trout
por: Ahmed, Ridwan O., et al.
Publicado: (2023)

Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout
por: Shao, Tiejuan, et al.
Publicado: (2017)

Feasibility of single-session endoscopic ultrasound-guided liver biopsy and endoscopic retrograde cholangiopancreatography in liver transplant recipients with abnormal liver function tests
por: Han, Samuel, et al.
Publicado: (2023)

287. Fecal Microbiome and Microbial Metabolites Predict Postoperative Enteroccoccus and Enterobacterales Infections in Liver Transplant
por: Lehmann, Christopher, et al.
Publicado: (2023)

Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience
por: Dizdar, Oguzhan Sitki, et al.
Publicado: (2016)

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant
por: He, Min, et al.
Publicado: (2019)

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
por: Wang, Baohong, et al.
Publicado: (2016)

Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
por: Wei, Xiao, et al.
Publicado: (2013)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

The gut microbiome and metabolome in kidney transplant recipients with normal and moderately decreased kidney function
por: Lan, Yang, et al.
Publicado: (2023)

Use of Nuclear Morphometry Characteristics to Distinguish between Normal and Abnormal Cervical Glandular Histologies
por: Swartz, Richard, et al.
Publicado: (2003)

Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients
por: Tu, Zhen-Hua, et al.
Publicado: (2022)

Obese dogs exhibit different fecal microbiome and specific microbial networks compared with normal weight dogs
por: Kim, Hanbeen, et al.
Publicado: (2023)

Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease
por: Si, Jiyeon, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

Temporal dynamics of the plasma microbiome in recipients at early post-liver transplantation: a retrospective study
por: Okumura, Toshihiko, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis
por: Zhu, Xuming, et al.
Publicado: (2022)

Activated CD4(+) T Cells and Highly Differentiated Alloreactive CD4(+) T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients
por: Duizendstra, Aafke A., et al.
Publicado: (2021)

Liver retransplantation for adult recipients
por: Hwang, Shin, et al.
Publicado: (2013)

Hyperhomocysteinaemia in liver transplant recipients
por: Nkansa-Dwamema, David, et al.
Publicado: (2004)

The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome
por: Kazemian, Negin, et al.
Publicado: (2020)

Gut microbiota of liver transplantation recipients
por: Sun, Li-Ying, et al.
Publicado: (2017)

Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs
por: Pilla, Rachel, et al.
Publicado: (2020)

Feasibility of using marginal liver grafts in living donor liver transplantation
por: Lan, Xiang, et al.
Publicado: (2018)

Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals
por: Cui, Guangying, et al.
Publicado: (2022)

Donor age and body weight determine the effects of fecal microbiota transplantation on growth performance, and fecal microbiota development in recipient pigs
por: Wang, Xiaofan, et al.
Publicado: (2022)

The fecal microbiota of healthy donor horses and geriatric recipients undergoing fecal microbial transplantation for the treatment of diarrhea
por: McKinney, Caroline A., et al.
Publicado: (2020)

Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice
por: Yuan, Chunchun, et al.
Publicado: (2023)

Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Defining Normal Liver Stiffness Range in a Normal Healthy Chinese Population without Liver Disease
por: Fung, James, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation
por: Zhang, Xi, et al.
Publicado: (2020)

Feasible management of median arcuate ligament syndrome in orthotopic liver transplantation recipients
por: Li, Shu-Xuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ckq3g0nfu3v0f4qje5j4m28tlj